Nasic (Xylometazoline Hydrochloride, Dexpanthenol)

Xylometazoline Hydrochloride, the active ingredient in Nasic, is an alpha‑adrenergic agonist presented as a nasal spray for intranasal use. It reduces swelling of the nasal mucosa, providing rapid relief of nasal congestion in adults and children suffering from the common cold, allergic rhinitis, or sinus irritation.

GNH USA supplies Nasic as a licensed, GDP‑compliant international pharmaceutical supplier, providing reliable sourcing and regulatory support to hospitals, pharmacies, and clinics worldwide, with efficient logistics for timely delivery across multiple global markets.

Nasic, containing xylometazoline hydrochloride and dexpanthenol, works on nasal vascular tone and mucosal healing to relieve congestion.

- Nasal congestion: rapid decongestion of swollen nasal passages. - Common cold: alleviates blockage and improves breathing during viral upper respiratory infection. - Allergic rhinitis: reduces nasal swelling caused by allergen exposure.

Nasic may cause local and systemic reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation. - Dryness of nasal mucosa. - Sneezing. - Headache. - Altered taste perception. - Mild epistaxis.

Serious or Rare Side Effects: - Severe hypertension or hypertensive crisis. - Cardiac arrhythmia. - Nasal ulceration or perforation with prolonged use. - Anaphylactic reaction. - Vision disturbances. - Persistent nasal bleeding.

Use Nasic according to label instructions and medical advice.

- Limit duration of use: avoid continuous use longer than 7 days to prevent rebound congestion. - Hypertension caution: monitor blood pressure if patient has high blood pressure. - Pediatric restriction: not recommended for children under 2 years of age. - Pregnancy and lactation: consult a healthcare professional as safety has not been established. - Concomitant nasal decongestants: avoid using other topical decongestants simultaneously. - Store at room temperature: keep in original container, protect from moisture and heat.

Nasic can interact with other sympathomimetic agents and systemic medications.

Major Interactions (Avoid): - Other nasal or oral decongestants (e.g., phenylephrine, pseudoephedrine): additive vasoconstriction may increase cardiovascular risk. - Monoamine oxidase inhibitors (MAOIs): combined use may precipitate hypertensive crisis. - β‑blockers: may diminish decongestant effect and alter cardiovascular response.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs: possible reduction in blood‑pressure‑lowering effect. - Antidepressants (SSRIs, SNRIs): monitor for increased blood pressure. - Alcohol: may enhance dizziness or headache.